DOCSLIB.ORG

Read More/Download

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Read More/Download 2016 Scientific Program – Charlottetown, PEI Sunday Sir John A. MacDonald Ballroom Coles Ballroom Henry Johnson Room June 12 07:30 – 07:40 President’s Opening Remarks – P. Spafford, Saskatoon, SK OVERALL LEARNING OBJECTIVES 07:40 – 07:45 Scientific Program Chair’s Opening Remarks – B. Rotenberg, This meeting provides learners in the specialty of Otolaryngology – Head and Neck Surgery (including general and London, ON subspecialty otolaryngologists as well as resident and medical student trainees) a significant opportunity to attend 07:45 – 07:50 Introduction of the Guest of Honour Dr. Patrick Gore-Hickman, sessions of interest and acquire further understanding and knowledge in areas of perceived / unperceived weakness in Saskatoon, SK – P. Spafford, Saskatoon, SK the specialty. All branches of the specialty, including head & neck oncology, laryngology, rhinology, otology, neurotology, 07:50 – 08:05 Guest of Honour Presentations – P. Gore-Hickman, Saskatoon, SK pediatric otolaryngology, facial plastic and reconstructive surgery, general otolaryngology, sleep disorders, and medical 08:05 – 08:10 Introduction of the Lifetime Achievement Award Recipient, Dr. education, are part of the program. Patrick Gullane, Toronto, ON – P. Spafford, Saskatoon, SK 08:10 – 08:25 Lifetime Achievement Award Recipient Presentation – P. Gullane, Building on the success of last year, we will run three concurrent sessions of workshops and podium presentations. New Toronto, ON this year is the addition of an extra day of general, subspecialty and resident sessions, as well as a series of debates. This 08:25 – 08:30 Introduction of Guest Speaker Dr. Mark Urken, New York, NY – P. provides delegates with a great variety of learning opportunities. As always, there will be ample time allotted for enhanced Spafford, Saskatoon, SK dialogue, discussion and interaction with the various presenters. In keeping with the theme of this year’s meeting, guest 08:30 – 09:10 The Evolving Significance of Metastatic Lymph Nodes in speakers will present their areas of expertise through plenary talks and workshops. Increased numbers of workshops will Papillary Thyroid Cancer. Do Changes in the ATA Clinical give each learner practical and adoptable knowledge to use immediately in practice when they return home. We will also Practice Guidelines Make Sense?– M. Urken, New York, NY have a series of pre-convention courses designed to give impactful hands-on experience to attendees. Also addressed in 09:10 – 09:15 Introduction of “Celebrating Our Own” Recipient Dr. Emad this year’s program will be workshops and presentations for the community-based practitioners, continued information on Massoud, Halifax, NS – B. Rotenberg, London, ON technological advancements in education, and popular updates in a variety of topics. 09:15 – 09:30 Presentation – E. Massoud, Halifax, NS 09:30 – 09:35 Introduction of “Celebrating Our Own” Recipient Dr. Albino Chiodo, Toronto, ON – B. Rotenberg, London, ON 09:35 – 09:50 Presentation – A. Chiodo, Toronto, ON 09:50 – 10:00 Editorial Awards – H. Seikaly, E. Wright, Edmonton, AB 10:00 – 10:30 Coffee: Visit Exhibits / Posters 10:30 – 10:35 Introduction of Guest Speaker Dr. Dennis Poe, Boston, MA – P. Spafford, Saskatoon, SK 10:35 – 11:15 Diagnosis and Management of Eustachian Tube Dilatory Dysfunction – D. Poe, Boston, MA 11:15 – 12:15 GREAT DEBATE: “Be it resolved that Otolaryngology-Head & Neck Surgery in Canada is overly sub-specialized” – Chair: G. Osler, Winnipeg, MB; Moderator: B. Westerberg, Vancouver, BC; Panelists: L. Nguyen, Montreal, QC, G. Thompson, Fredericton, NB, K. Chueng, Stratford, ON, I. Witterick, Toronto, ON 12:15 – 13:30 Lunch: Visit Exhibits / Posters Lunch: Visit Exhibits / Posters Lunch: Visit Exhibits / Posters 13:30 – 14:30 WS #1 WS #2 13:30 – 14:15 WS #3 Diagnosis and Treatment of Semicircular Canal Dehiscence Patient-centred Treatment Selection for Laryngeal Cancer in Periorbital Rejuvenation Part I: Upper Lid Blepharoplasty – Syndrome (SCDS) – L. Parnes, London, ON, D. Poe, Boston, MA, I. the Era of IMRT and Transoral Surgery – A. Christopoulos, T. M. Samaha, Montreal, QC Saliba, Montreal, QC Ayad, L Guertin, E. Bissada, Montreal, QC PAPERS: OTOLOGY 1 PAPERS: HEAD AND NECK SURGERY 1 14:15 – 15:00 WS #4 CO-CHAIRS: Dr. Jane Lea, Vancouver, BC CHAIR: Dr. Donna Sutherland, Winnipeg, MB Periorbital Rejuvenation Part II: Lower Blepharoplasty – M. Dr. Dennis Poe, Boston, MA Samaha, Montreal, QC 14:30 – 14:37 Delayed Facial Nerve Decompression for Severe Refractory Staging Non-melanoma Skin Cancer Metastasis to the Cases of Bell’s Palsy: A 25-year Experience – M.E. Nader, I. Parotid Gland – K. Higgins, L. Czerwonka, Toronto, ON, J. Dort, Berania, Montreal, QC, M. Awad, Sherbrooke, QC, J.J. Dufour, I. Calgary, AB Saliba, Montreal, QC Sunday Sir John A. MacDonald Ballroom Coles Ballroom Henry Johnson Room June 12 Otology 1 cont… Head and Neck 1 cont… WS#4 cont… 14:37 – 14:44 Endolymphatic Duct Blockage: A Randomized Controlled Trial of A Continuing Epidemic of Human Papillomavirus Related a Novel Surgical Technique for Meniere’s Disease Treatment – I. Oropharyngeal Cancer in Southwestern Ontario – A. Nichols, Saliba, N. Gabra, M.H. Asmar, A. Alhabib, D. Berbiche, Montreal, QC S. Dhaliwal, J. Basmaji, J. Yoo, K. Fung, D. MacNeil, J. Barrett, J. Mymryk, London, ON 14:44 – 14:51 Hearing Changes in the Contralateral Ear in Hearing Preservation Adherence to Guideline-recommended Process Measures for Cochlear Implantation Surgery – G. Kurien, L. Smith, H. Euna, J. Squamous Cell Carcinoma of the Head and Neck in Ontario: Chen, J. Nedzelski, V. Lin, Toronto, ON Impact of Surgeon and Hospital Volume – T. Eskander, E. Monteiro, J. Irish, P. Gullane, R. Gilbert, J. De Almeida, D. Brown, D. Goldstein, Toronto, ON 14:51 – 14:58 Discussion Discussion 14:58 – 15:05 Hearing Loss and Social Engagement in Older Canadians – P. An Oral Cavity Wait Time Improvement Initiative: Do Wait Mick, Kelowna, BC, M. Parfyonov, Toronto, ON, K. Pichora-Fuller, Times to Surgery and Post-operative Radiation Matter? – A. Vancouver, BC Nichols, N. Mundi, S. Dhaliwal, J. Basmaji, J. Yoo, K. Fung, D. MacNeil, D. Palma, London, ON 15:05 – 15:12 Middle Ear Diagnostic Imaging in vivo using Optical Coherence Heat and Moisture Exchanger Use Reduces In-Hospital Tomography (OCT) – N. Jufas, D. MacDougall, J. Farrell, T. K. Complications Following Total Laryngectomy – K. Higgins, D. Landry, J.A. Brown, R.B.A. Adamson, G. Earle, M. Bance, Halifax, NS Enepekides, A. Foreman, Toronto, ON 15:12 – 15:19 Discussion Discussion 15:15 – 15:45 Coffee: Visit Exhibits / Posters Coffee: Visit Exhibits / Posters Coffee: Visit Exhibits / Posters PAPERS: GENERAL PAPERS: HEAD AND NECK SURGERY 2 PAPERS: ENDOCRINE SURGERY CHAIR: Dr. Albino Chiodo, Toronto, ON CO-CHAIRS: Dr. John de Almeida, Toronto, ON CO-CHAIRS: Dr. R. Payne, Montreal, QC Dr. Claudio Vicini, Forli, Italy Dr. M. Urken, New York, NY 15:45 – 15:52 Aloe Vera versus Control for Treatment of Lichen Planus and TORS vs. RT: Development of a Decision Board for patients Detection of Circulating Thyroid Tumor DNA in Patients with Burning Mouth Syndrome: A Systematic Review and Meta- with early Oropharyngeal Cancer – G. Scott, A. Louie, D. Thyroid Nodules – K. Patel, N. Cormier, J. Barrett, J. Yoo, D. analysis – D. Choi, N. Cohen, M. Gupta, Hamilton, ON MacNeil, A. Nichols, D. Palma, J. Yoo, K. Fung, London, ON MacNeil, I. Radchinsky, W. Stecho, A. Nichols, London, ON 15:52 – 15:59 Attitudes of Health Care Professionals towards E-mail The Role of Chemotherapy in Oropharyngeal Cancer Patients Highly Effective Agents Identified by High-throughput Communication with Patients – S. Kohlert, S. Barnes, S. Treated with Surgery and Post-operative Radiation – V. Screening of Genetically Characterized Anaplastic Thyroid Richardson, J.P. Vaccani, Ottawa, ON Biron, F. Makki, H. Zhang, L. Puttagunta, D. O’Connell, J. Harris, Cancer Cell Lines – N. Pinto, M. Black, J. Yoo, D. MacNeil, K. H. Seikaly, Edmonton, AB Fung, London, ON, A. Datti, Toronto, ON, J. Barrett, A. Nichol, London, ON 15:59 – 16:06 Hearing Loss as a Risk Factor for Injury-related Health Care TORS for Head and Neck Cancer of Unknown Primary: The How Does Your Thyroid Practice Compare to the Rest of the Expenditures – P. Mick, Kelowna, BC, D. Foley, F. Lin, Baltimore, Quebec Experience – M. Roskies, M. Mascarella, A. World? Taking a Look at the New ATA Guidelines and the MD Christopoulos, A. Mlynarek, M. Hier, L. Guertin, K. Richardson, First International Thyroid Surgery Survey – A. Maniakas, T. Montreal, QC Ayad, Montreal, QC 16:06 – 16:13 Discussion Discussion Discussion 16:13 – 16:20 Hyaluronic Acid Fat Graft Myringoplasty vs Autologous Platelet Transoral Robotic Surgery with Free Flap Reconstruction: Outpatient versus Inpatient Thyroidectomy: A Systematic Rich Plasma Myringoplasty – I. Saliba, S. Alhabib, Montreal, QC Case Control Analysis – V. Biron, J. Chung, D. O’Connell, J. Review and Meta-analysis – D. Lee, C. Chin, C. Hong, I. Harris, Edmonton, AB Witterick, Toronto, ON 16:20 – 16:27 Impact of Marginalization Status on Smoking Cessation in Virtual Planning and Surgical Simulation in Maxillary The McGill Thyroid Nodule Score’s (MTNS) Role in the Individuals Diagnosed with Head and Neck Cancer: A Multicentre Reconstruction – H. Seikaly, H. Logan, D. O’Connell, J. Harris, Investigation of Thyroid Nodules with Benign Ultrasound Investigation – G. Scott, London, ON, C. Best, H. Amoodi, Sault K. Ansari, S. Nayar, M. Oswald, J. Wolfaardt, Edmonton, AB Guided FNA Biopsies – S. Khalifé, S. Bouhabel, V.I. Forest, M. Ste. Marie, ON, K. Fung, London, ON, M. Gupta, D. Sommer, Hier, L. Rochon, M. Tamilia, R. Payne, Montreal, QC Hamilton, ON, C. Szeto, D. Micomonico, Sault Ste. Marie, ON 16:27 – 16:34 Improving the Perioperative Patient Experience: A web-based Patterns of Neck Metastatis in p16 Positive and Negative Use of Droplet Digital PCR for Ultrasensitive Gene Application Guiding Patients Through Their Surgical Experience - Oropharyngeal Squamous Cell Carcinoma – J. Clark, H. Expression Profiling and Mutational Analysis of Thyroid FNA Y.
Load more

Recommended publications
  • Otoplasty-Plastic Surgery of the Ears (Pdf)
    Vinod K. Anand, MD, FACS Nose and Sinus Clinic Plastic Surgery of the Ears (Otoplasty) This brochure will familiarize you with some basic facts about cosmetic surgery of the ear. It will give you enough general background to make you an "educated consumer." Your facial plastic surgeon will explain how this procedure applies to an individual's condition. A SOLUTION FOR A VERY COMMON PROBLEM The most common cosmetic problem that people have with their ears is that they pro- trude. Otoplasty is the name given to the operation designed to "pin back" the ears and to change their shape and contour. While otoplasty can be performed at any age after four or five years, it often is recom- mended in the preschool years to alleviate possible teasing at school by other children. DECIDING ON AN OPERATION Anyone interested in cosmetic surgery of the ear for himself or a child should consult a competent facial plastic surgeon. During the initial visit, the surgeon makes a thorough evaluation of the ears to determine whether surgery is indicated. The surgeon will then discuss any questions and concerns related to the surgery. In addition to the skill of the surgeon, the patient's realistic expectations about the results of the surgery and his general emotional state are important considerations. Mental attitude is as important as the ability to heal in evaluating candidates for facial plastic surgery. Once surgery is agreed upon, pre-operative photographs are taken to help the surgeon plan the operation. These photographs usually are compared with similar ones taken sometime after surgery and serve as a permanent before-and-after record of the results.
    [Show full text]
  • The Posterior Muscles of the Auricle: Anatomy and Surgical Applications
    Central Annals of Otolaryngology and Rhinology Research Article *Corresponding author Christian Vacher, Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, APHP, 100, The Posterior Muscles of the Boulevard Général Leclerc, 92110 Clichy, France, Tel: 0033140875671; Email: Submitted: 19 December 2014 Auricle: Anatomy and Surgical Accepted: 16 January 2015 Published: 19 January 2015 Applications Copyright © 2015 Vacher et al. Rivka Bendrihem1, Christian Vacher2* and Jacques Patrick Barbet3 OPEN ACCESS 1 Department of Dentistry, University of Paris-Descartes, France Keywords 2 Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, France • Auricle 3 Department of Pathology and Cytology, University of Paris-Descartes, France • Anatomy • Prominent ears Abstract • Muscle Objective: Prominent ears are generally considered as primary cartilage deformities, but some authors consider that posterior auricular muscles malposition could play a role in the genesis of this malformation. Study design: Auricle dissections of 30 cadavers and histologic sections of 2 fetuses’ ears. Methods: Posterior area of the auricle has been dissected in 24 cadavers preserved with zinc chlorure and 6 fresh cadavers in order to describe the posterior muscles and fascias of the auricle. Posterior auricle muscles from 5 fresh adult cadavers have been performed and two fetal auricles (12 and 22 weeks of amenorhea) have been semi-serially sectioned in horizontal plans. Five µm-thick sections were processed for routine histology (H&E) or for immuno histochemistry using antibodies specific for the slow-twitch and fast-twich myosin heavy chains in order to determine which was the nature of these muscles. Results: The posterior auricular and the transversus auriculae muscles looked in most cases like skeletal muscles and they were made of 75% of slow muscular fibres.
    [Show full text]
  • Otolaryngology Head & Neck Surgery Residency Manual
    OTOLARYNGOLOGY HEAD & NECK SURGERY RESIDENCY MANUAL Carol A Bauer, MD –Professor and Chair, Residency Program Director Dana L Crosby, MD – Associate Program Director Sandra Ettema, MD, PhD – Associate Program Director Jenny Kesselring, C-TAGME - Residency Program Coordinator (217-545-4777) Updated 6/21/2017 TABLE OF CONTENTS INTRODUCTION ............................................................................................................................ 2 ADMINISTRATIVE INFORMATION .................................................................................................. 3 GENERAL EXPECTATIONS OF OTOLARYNGOLOGY RESIDENTS ..................................................... 3 CHIEF RESIDENT EXPECTATIONS AND RESPONSIBILITIES ............................................................ 8 OTOLARYNGOLOGY DUTY HOUR POLICY .................................................................................. 11 TRAVEL POLICY ......................................................................................................................... 13 VACATION / LEAVE OF ABSENCE POLICY .................................................................................. 15 OVERVIEW OF EDUCATIONAL GOALS, OBJECTIVES AND COMPETENCIES .................................. 21 THE CURRICULUM GUIDE .......................................................................................................... 25 TEACHING GOALS AND OBJECTIVES .......................................................................................... 28 RESEARCH GOALS AND
    [Show full text]
  • Otoplasty in an Operation Performed to Reduce One Or Both Prominent Ears
    What is an otoplasty? Otoplasty in an operation performed to reduce one or both prominent ears. Children with prominent ears have excess cartilage in the bowl or concha that protruded the ear out away from the skull. They also have a missing fold called the antihelical crus in the upper part of the ear that further directs the ear out away from the head. 1:1000 children born in the US have this problem. What age is surgery performed? Surgery is typically performed at age 5-6 years, but any time after age 5 is ok. Surgery performed before age 5 is rare due to concerns about ear growth after the operation. What should be done before surgery? A recent history and physical documenting good health is required one week or less before the surgery. No lab tests are required except in special circumstances. No eating or drinking after midnight, the night before the operation unless otherwise instructed . How is the operation performed? There are many types of otoplasty procedures. They range from simple cartilage to removals, to otobrasion, to complex grafting and tissue rearrangements. In our practice all the various procedures are performed based on the need of the patient. However, the most common type of otoplasty we use is the Lucket Otoplasty. This procedure involves 4 parts. • 1. Skin reduction • 2. Concha bowl reduction • 3. Concha-mastoid suturing • 4. Sculpting of the antihelical fold in the flattened upper quadrant of the ear How long is the surgery? The surgery typically takes 1 hour per ear depending of the degree of severity.
    [Show full text]
  • Postoperative Instructions – Otoplasty, Ear Pinning Surgery
    Postoperative Instructions – Otoplasty, Ear Pinning Surgery Maximize your cosmetic results after protruding ear surgery by following these basic post- treatment instructions. Please contact the office with any questions. General • Numbness around the ear is common • Severe ear pain might indicate a hematoma (blood collection) or infection, and the office must be notified immediately • No smoking or alcohol • No aspirin, ibuprofen, Motrin, Advil, or similar anti-inflammatory medication. You will be advised you when you may resume taking these medications. o Other blood thinners, such as Coumadin or Plavix, must also be discontinued, under the guidance of your primary care physician. • No herbal medications, supplements, or teas. o Increased risk of bleeding include, but are not limited to Vitamin E, garlic, ginger, ginkgo, ginseng, kava, and St. John's Wort, fish oil, and green tea o Arnica montana herbal tablet may help reduce bruising and swelling Diet • Advance slowly from liquids to soft, then solid foods after anesthesia. No restrictions on specific type of food or drink. Drink plenty of fluids. Do not chew gum. Activity • Sleep with your head elevated for the first 48 hours, to help reduce facial swelling • Do NOT blow nose. • Avoid sneezing. If unable to avoid sneezing, then sneeze with your mouth open • Do NOT bend over or hang your head down. • No heavy lifting, straining, strenuous activity, or sex for at least 2 weeks. • Caution while using a hair brush, hair dryer, or clothes which may catch or snag the ear • Do NOT wear any earrings for 2 weeks. • No contact sports for 6 weeks.
    [Show full text]
  • Otoplasty and External Ear Reconstruction
    Medical Coverage Policy Effective Date ............................................. 4/15/2021 Next Review Date ....................................... 4/15/2022 Coverage Policy Number .................................. 0335 Otoplasty and External Ear Reconstruction Table of Contents Related Coverage Resources Overview .............................................................. 1 Cochlear and Auditory Brainstem Implants Coverage Policy ................................................... 1 Prosthetic Devices General Background ............................................ 2 Hearing Aids Medicare Coverage Determinations .................... 5 Scar Revision Coding/Billing Information .................................... 5 References .......................................................... 6 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which
    [Show full text]
  • ASC Hearing Clinic Michigan
    ENT Services ENT Services Hearing Aid Options ASC Hearing Services Throat Disorders and Treatment Micro-CIC® (Completely-In-The- • Tonsil and adenoid surgery Canal) • Snoring, sleep apnea surgery (UPPP, palate advancement, • Smalllest, custom-designed, deep tongue base treatment, radio frequency treatment of the ftting hearing aid palate and tongue) • Nearly invisible • Thyroid surgery • Appropriate for mild to moderate • Vocal cord and voice disorders: Hoarseness losses • Laryngeal/pharyngeal refex: GERD • Swallowing disorders ITC (In-The-Canal) • Smaller and more discrete than ITE Head and Neck Disorders and Treatment style aids Complete Hearing Evaluation • Salivary gland surgery • Ofers additional user control Determines the degree and type of hearing loss • Neck masses functions • Thyroglossal duct cyst • Appropriate for mild to moderate Impedance and Immittance Testing • Lymph node excision losses Evaluates middle ear structure for eardrum abnormalities, Eu- • Tracheostomy stachian tube dysfunction, middle ear efusion (fuid), otoscle- rosis Facial Plastic Surgery/Skin Cancer and Treatment ITE (In-The-Ear) • Lesion removal for skin cancer with or without • More visible in the ear • Features the widest user control Video Otoscopy reconstruction: basal, squamous cell, melanoma Examines outer ear and eardrum • Reconstruction following MOHS procedures functions • Mid face and nasal fracture • Appropriate for mild to severe • Blephoraplasty losses Otoacoustic Emmission Testing (OAE) Evaluates outer hair cell function/inner ear • Cosmetic
    [Show full text]
  • Effectiveness of the Epleys Maneuver for Treatment of Benign Paroxysmal
    Effectiveness of the Epleys Maneuver for Treatment of Benign Paroxysmal Positional Vertigo Salah Uddin Ahmmed1, Md Zakir Hossain2,Mohammad Neser Uddin2, Sarder Mohammad Golam Rabbani2, Arba Md Shaon Mursalin Alman3. Abstract Background: Benign Paroxysmal Positional Vertigo (BPPV) is one of the most frequent vestibular disorder. It is characterized by recurrent spells of vertigo associated with certain head movements such as turning the head to right or left, getting out of bed, looking up and bending down. Objectives: The aim of this study was to compare the efficacy of treatment by the Epley maneuver with medicine and medicine (betahistine) only for benign paroxysmal positional vertigo. Materials and Methods: Fifty six patients with benign paroxysmal positional vertigo were randomly divided in two groups. One group was treated with Epley maneuver wth medicine as case and other group with only medicine (betahistine) as control. Results: At the end of first week who were treated with Epley maneuver with medicine, 24 (85.71%) patients recovered and 27 (96.42%) were recovered at second week and all the 28 (100%) were found recovered at end of third week. Whereas, who treated with betahistine only 7(25.00%) recovered at end of first week 22 (78.58%) recovered at second week, 25 (89.29%) recovered at third week and all the 28 (100%) were at end of fourth week. Who received only medical therapy needed one more extra visit than case patients Conclusion: Treatment of BPPV with the Epleys manouvre with medicine resulted in early better and improvement of symptoms than with medicine alone. Keywords: Benign paroxysmal positional vertigo, Epleys manouvre, betahistine.
    [Show full text]
  • Code Procedure Cpt Price University Physicians Group
    UNIVERSITY PHYSICIANS GROUP (UPG) PRICES OF PROVIDER SERVICES CODE PROCEDURE MOD CPT PRICE 0001A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 1ST DOSE 0001A $40.00 0002A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 2ND DOSE 0002A $40.00 0011A IMM ADMN SARSCOV2 100 MCG/0.5 ML 1ST DOSE 0011A $40.00 0012A IMM ADMN SARSCOV2 100 MCG/0.5 ML 2ND DOSE 0012A $40.00 0021A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 1ST DOSE 0021A $40.00 0022A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 2ND DOSE 0022A $40.00 0031A IMM ADMN SARSCOV2 AD26 5X10^10 VP/0.5 ML 1 DOSE 0031A $40.00 0042T CEREBRAL PERFUS ANALYSIS, CT W/CONTRAST 0042T $954.00 0054T BONE SURGERY USING COMPUTER ASSIST, FLURO GUIDED 0054T $640.00 0055T BONE SURGERY USING COMPUTER ASSIST, CT/ MRI GUIDED 0055T $1,188.00 0071T U/S LEIOMYOMATA ABLATE <200 CC 0071T $2,500.00 0075T 0075T PR TCAT PLMT XTRC VRT CRTD STENT RS&I PRQ 1ST VSL 26 26 $2,208.00 0126T CAROTID INT-MEDIA THICKNESS EVAL FOR ATHERSCLER 0126T $55.00 0159T 0159T COMPUTER AIDED BREAST MRI 26 26 $314.00 PR RECTAL TUMOR EXCISION, TRANSANAL ENDOSCOPIC 0184T MICROSURGICAL, FULL THICK 0184T $2,315.00 0191T PR ANT SEGMENT INSERTION DRAINAGE W/O RESERVOIR INT 0191T $2,396.00 01967 ANESTH, NEURAXIAL LABOR, PLAN VAG DEL 01967 $2,500.00 01996 PR DAILY MGMT,EPIDUR/SUBARACH CONT DRUG ADM 01996 $285.00 PR PERQ SAC AGMNTJ UNI W/WO BALO/MCHNL DEV 1/> 0200T NDL 0200T $5,106.00 PR PERQ SAC AGMNTJ BI W/WO BALO/MCHNL DEV 2/> 0201T NDLS 0201T $9,446.00 PR INJECT PLATELET RICH PLASMA W/IMG 0232T HARVEST/PREPARATOIN 0232T $1,509.00 0234T PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, RENAL
    [Show full text]
  • Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo
    OTOXXX10.1177/0194599816689667Otolaryngology–Head and Neck SurgeryBhattacharyya et al 6896672017© The Author(s) 2010 Reprints and permission: sagepub.com/journalsPermissions.nav Clinical Practice Guideline Otolaryngology– Head and Neck Surgery Clinical Practice Guideline: Benign 2017, Vol. 156(3S) S1 –S47 © American Academy of Otolaryngology—Head and Neck Paroxysmal Positional Vertigo (Update) Surgery Foundation 2017 Reprints and permission: sagepub.com/journalsPermissions.nav DOI:https://doi.org/10.1177/0194599816689667 10.1177/0194599816689667 http://otojournal.org Neil Bhattacharyya, MD1, Samuel P. Gubbels, MD2, Seth R. Schwartz, MD, MPH3, Jonathan A. Edlow, MD4, Hussam El-Kashlan, MD5, Terry Fife, MD6, Janene M. Holmberg, PT, DPT, NCS7, Kathryn Mahoney8, Deena B. Hollingsworth, MSN, FNP-BC9, Richard Roberts, PhD10, Michael D. Seidman, MD11, Robert W. Prasaad Steiner, MD, PhD12, Betty Tsai Do, MD13, Courtney C. J. Voelker, MD, PhD14, Richard W. Waguespack, MD15, and Maureen D. Corrigan16 Sponsorships or competing interests that may be relevant to content are associated with undiagnosed or untreated BPPV. Other out- disclosed at the end of this article. comes considered include minimizing costs in the diagnosis and treatment of BPPV, minimizing potentially unnecessary re- turn physician visits, and maximizing the health-related quality Abstract of life of individuals afflicted with BPPV. Action Statements. The update group made strong recommenda- Objective. This update of a 2008 guideline from the American tions that clinicians should (1) diagnose posterior semicircular Academy of Otolaryngology—Head and Neck Surgery Foun- canal BPPV when vertigo associated with torsional, upbeating dation provides evidence-based recommendations to benign nystagmus is provoked by the Dix-Hallpike maneuver, per- paroxysmal positional vertigo (BPPV), defined as a disorder of formed by bringing the patient from an upright to supine posi- the inner ear characterized by repeated episodes of position- tion with the head turned 45° to one side and neck extended al vertigo.
    [Show full text]
  • A Practical Approach to Assessment and Treatment of Benign Paroxysmal Positional Vertigo Combining Research and Clinical Practice
    A Practical Approach to Assessment and Treatment of Benign Paroxysmal Positional Vertigo Combining research and Clinical Practice Naseem Chatiwala, PT, DPT, MS, NCS Board certified Neuro Clinical Specialist Certified Vestibular Specialist Workshop Objectives • Analyze normal and abnormal anatomy and physiology of the vestibular system • Recognize signs and symptoms of BPPV and confidentially identify variants of BPPV • Explain physiologic rationale of test procedures and results of various test for BPPV • Utilize results of clinical examination to develop treatment plans • Be able to identify treatment procedure Overview • In the USA, 1.7 million people sustain a TBI each year • 30% and 65% of people with TBI suffer from some form of dizziness and/or have balance problems at some point during their recovery • 28% of individuals with head trauma have BPPV • A smaller study, of 69 patients with chronic BPPV, found a history of head or neck trauma in 81% of the cohort Pisani et al, 2015 Iglebekk W, 2017 Definitions • Vertigo • Disequilibrium • Presyncope • Floating or rocking sensation • Light headedness ?? DIZZY?? 4 Anatomy and Physiology • 3 Components – Peripheral sensory Apparatus • Motion sensors – Central processor • Vestibular nuclear complex and Cerebellum – Motor output • To ocular muscles and spinal cord Central Sensory Input Motor Output Processor 5 Peripheral Sensory Apparatus [ Motion Sensors] Three Semicircular Canals Lateral, Anterior (superior) and posterior Two Otolith Organs Utricle Saccule 6 • Lateral Canal: Angled at 30°
    [Show full text]
  • Epley Manoeuvre for Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo in People with Multiple Sclerosis: Protocol of a Randomised Controlled Trial
    Open access Protocol BMJ Open: first published as 10.1136/bmjopen-2020-046510 on 18 March 2021. Downloaded from Epley manoeuvre for posterior semicircular canal benign paroxysmal positional vertigo in people with multiple sclerosis: protocol of a randomised controlled trial Cristina García- Muñoz ,1 María- Dolores Cortés- Vega ,1 Juan Carlos Hernández- Rodríguez ,2 Rocio Palomo- Carrión,3 Rocío Martín- Valero ,4 María Jesús Casuso- Holgado 1 To cite: García- Muñoz C, ABSTRACT Strengths and limitations of this study Cortés- Vega M- D, Hernández- Introduction Vestibular disorders in multiple sclerosis (MS) Rodríguez JC, et al. Epley could have central or peripheral origin. Although the central ► This randomised controlled trial will be the first to manoeuvre for posterior aetiology is the most expected in MS, peripheral damage is semicircular canal benign address knowledge gap on the effectiveness of the also significant in this disease. The most prevalent effect of paroxysmal positional vertigo in Epley manoeuvre in a multiple sclerosis population. vestibular peripheral damage is benign paroxysmal positional people with multiple sclerosis: ► Double- blind and concealed allocation will reduce vertigo (BPPV). Impairments of the posterior semicircular protocol of a randomised the possibility of bias. controlled trial. canals represent 60%–90% of cases of BPPV. The standard BMJ Open ► Videonystagmography goggles will enable the pri- gold treatment for this syndrome is the Epley manoeuvre (EM), 2021;11:e046510. doi:10.1136/ mary outcome of the research to be measured more bmjopen-2020-046510 the effectiveness of which has been poorly studied in patients objectively. with MS. Only one retrospective research study and a case ► Prepublication history and ► The Epley manoeuvre is an easy and quick vestib- study have reported encouraging results for EM with regard additional material for this ular treatment that results in significant changes in to resolution of posterior semicircular canal BPPV.
    [Show full text]